ArticleClinical kidney journal2024

SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?

Marieta P Theodorakopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.